Pharma Profits
-
The TRIPs waiver and India: A misadventure and a compromise in Geneva by the government
The country has already exported millions of vaccines while more lie unused. Another reason may be that the Centre realised not much would change on the ground.
Yogesh Pai & Prashant Reddy T
-
United States is approving drugs by the dozen. Why is it worrying Indian pharma companies?
Their profits may suffer from increased competition as well as wholesale and retail suppliers teaming up to procure generic medicines.
Sriram Iyer, qz.com
-
India’s oldest drugmaker used some classic management tips to turn profitable after 64 years
Bengal Chemicals & Pharmaceuticals is now eyeing a profit of Rs 20 crore by 2020.
Manu Balachandran, qz.com
Trending
-
Constitution does not allow preferential treatment for religious majority: SC judge BV Nagarathna
-
Readers’ comments: ‘Most Kerala Hindus are already lost’
-
Thailand Open 2023: PV Sindhu knocked out in opening round; Kiran George stuns world No 9 Shi Yu Qi
-
In Narendra Modi’s embrace, Nepal’s ‘Prachanda’ looks to bolster his position – and Indian interests
-
Video: Watch this breakdancer’s amazing performance in sari and high heels